Low-dose aspirin significantly reduced colorectal cancer recurrence in patients with PI3K pathway gene alterations, nearly halving recurrence rates over three years compared to placebo. The study ...

Low-dose aspirin may slash colorectal cancer recurrence risk by 55%, according to a recent trial. Image credit: soleg/Getty Images The National Cancer Institute predicts that colorectal cancers will ...

An experimental cancer vaccine has shown promise in keeping certain cancers from coming back. In a phase 1 clinical trial led in part by the UCLA Health Jonsson Comprehensive Cancer Center, ...

Singapore, 17 March 2025 – A large-scale, international, multicentre, phase 3 clinical trial of aspirin for the secondary prevention of colorectal cancer has concluded. Led by Singapore ...

A groundbreaking study reveals that a daily low dose of aspirin can significantly reduce the risk of colorectal cancer ...

Berberine significantly reduced adenoma recurrence and colorectal neoplasm occurrence in a 6-year follow-up study of nearly 800 patients post-polypectomy. The study found that berberine's ...

A large-scale, international, multicentre, phase 3 clinical trial of aspirin for the secondary prevention of colorectal cancer has concluded. Led by Singapore clinician-scientists, the ASCOLT (Aspirin ...

Colon and rectal cancer disproportionately impact the Black community. A new study published in the Journal of Clinical Oncology suggests that a common over-the-counter drug may significantly reduce ...

New research has identified a protein that could serve as both a biomarker and therapeutic target to weaken stem-like cancer ...

Safety and Efficacy Study of Ablative Radiation Therapy for Large Liver Metastases Invading Into the Inferior Vena Cava and Heart Patients with CRC who develop locoregional recurrence exhibit a ...